Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

7.09
Delayed Data
As of 12:31pm ET
 -0.1399 / -1.93%
Today’s Change
5.60
Today|||52-Week Range
11.40
-5.97%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close7.23
Today’s open7.05
Day’s range7.05 - 7.09
Volume382
Average volume (3 months)6,687
Market cap$30.2M
Dividend yield--
Data as of 12:31pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+34.64%
P/E ratio20.1
Price/Sales2.32
Price/Book2.08

Competitors

 Today’s
change
Today’s
% change
CURNeuralstem Inc+0.01+4.89%
CLSNCelsion Corp+0.02+1.61%
VTGNVistaGen Therapeutic...-0.02-0.69%
KDUSCadus Corp+0.01+1.01%
Data as of 4:00pm ET, 06/28/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$10.2M
Annual profit (last year)$1.2M
Net profit margin11.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts

Partner Offers

Search for Jobs